Payment Disclosure

Patricia Quinn

$67,350
paid by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson »
Listed practitioner: Patricia Quinn
Location: Washington, D.C.
Payment for: Fees for Consulting, Speaker Bureau
Payment for: Fees for Consulting, Speaker Bureau
Reported: Jan. to Dec. 2010 Janssen Pharmaceuticals
Search for Patricia Quinn in Prescriber Checkup, our database of prescribing patterns within Medicare's drug program.

Notable drugs produced by Janssen Pharmaceuticals include:

Risperdal Consta (antipsychotic for schizophrenia and Bipolar I Disorder)
Invega (schizophrenia & schizoaffective disorder)
Invega Sustenna (schizophrenia)
Nucynta (painkiller)
Nucynta ER (painkiller)
Ortho Evra (contraceptive)
Ortho Tri-Cyclen LO (contraceptive)
Xarelto (reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, deep vein thrombosis, pulmonary embolism)

Important notes

The reports include both the name of the health provider who performed the service and, when reported, the entity paid. They may be different.

Source: Johnson & Johnson. ProPublica last downloaded this record on Dec. 19, 2012.

I think this is my doctor — what should I do?

If your provider is listed, it’s because a drug company reported paying him or her for promotional activities, meals, travel, educational items, consulting or research. Such payments are legal, but research has shown that drug-company marketing can influence what a doctor prescribes. How you can use this data »